CDK7 and breast cancer: One study, utilizing publicly available transcriptomic data from a specific group of TNBC patients (n = 383) and the METABRIC TNBC dataset (n = 217), identified that elevated CDK7 mRNA levels were synonymous with reduced relapse free survival (RFS) and poor breast cancer specific survival (BCSS).